Unlock instant, AI-driven research and patent intelligence for your innovation.

Human cytomegalovirus M epitope and application thereof to medical research field

A human cytomegalovirus and antigenic epitope technology, applied in antiviral agents, pharmaceutical formulations, antibody medical components, etc., can solve the problems of poor immunogenicity of antigenic epitope peptides, and the application research of antigenic epitope peptides is in the primary stage.

Inactive Publication Date: 2008-10-01
INST OF BASIC MEDICAL SCI ACAD OF MILITARY MEDICAL SCI OF PLA
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] In recent years, research on epitope peptides as candidate vaccines has received more and more attention. However, due to the poor immunogenicity of epitope peptides and the limitation of the development of immune adjuvants, the clinical application of epitope peptides is still in its infancy.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human cytomegalovirus M epitope and application thereof to medical research field
  • Human cytomegalovirus M epitope and application thereof to medical research field
  • Human cytomegalovirus M epitope and application thereof to medical research field

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1. Screening of Goat Anti-HCMV Antigen Epitopes

[0023] First, 100 μl goat anti-HCMV polyclonal antibody IgG was used to coat the enzyme-linked plate, and placed at 4°C overnight. After blocking with 3% BSA for 1 h, add a phage display random dodecapeptide library (NEB product), incubate at room temperature for 1 h, and wash non-specifically bound phage with TBST (50 mmol / L Tris-HCl, 0.1% TWEEN20, pH 7.5) , and then use 0.2mmol / L glycine-HCl pH2.2 to elute the specifically bound phage, and the eluate is neutralized with 1mol / L Tris-HCl pH9.0. According to the method provided by the product kit, the titer of the phage in the eluate was determined, and the titer of the eluted phage of normal goat serum IgG was used as a control to determine the P / N ratio. At the same time, the eluted phages combined with TRAP antibody IgG were amplified and their titers were determined for the next round of screening. After 4 rounds of screening, the measured P / N ratio was si...

Embodiment 2

[0024] Example 2. The screened antigenic epitope sequence is compared with the M protein sequence

[0025] Analysis of the screening antigen epitope sequence and the original sequence of the M protein revealed that the antigen epitope sequence was highly homologous to the 32-38 amino acid sequence of the M protein:

[0026] Epitope sequence × L x LSQ x P

[0027] M protein primary sequence 31 H L V LSN f P 38

Embodiment 3

[0028] Example 3. Epitope polyantibody competition inhibits goat anti-HCMV polyantibody binding to virions

[0029] The M antigen epitope was coupled with keyhole limpet hemocyanin (KLH) through covalent bonds, and Balb / C mice were immunized to obtain M antigen epitope polyantiserum. After protein A purification, the M antigen epitope polyclonal antibody with higher purity was obtained.

[0030]According to the method of the kit, the HCMV virus was coated on the wells of the ELISA plate, and after being blocked with 3% BSA for 1 hour, the epitope polyclonal antibody and goat anti-HCMV polyclonal antibody of different concentrations were added, incubated at room temperature for 1 hour, and washed with PBST (20mmol / L PBS, 0.5% Tween-20, pH7.5) wash, then add HRP-labeled rabbit anti-mouse secondary antibody, and use ECL solution to show the OD value of antigen mimotope antibody binding to virus. The experimental results found that with the increase of the amount of goat anti...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to M epitope in the glucoprotein of human cytomegalovirus outer virionic membranes and the application of the M epitope to preparing diagnostic reagents or bacterin of human cytomegalovirus or the application thereof in other medicine field.

Description

field of invention [0001] The present invention relates to the M antigen epitope in the outer membrane glycoprotein of human cytomegalovirus, and the application of the M antigen epitope in the preparation of human cytomegalovirus diagnostic reagent or vaccine or in other medical fields. Background of the invention [0002] Human cytomegalovirus (HCMV) is a kind of virus that is ubiquitous in nature but has strict species-specificity. It belongs to the β-herpesvirus subfamily. Human cytomegalovirus infection is very common in the population, but most of them are clinically indistinct or latent infection, and most people acquire immunity after being infected with HCMV in childhood or adolescence. In pregnant women, primary or new HCMV recurrent infection can cause neonatal intrauterine infection or perinatal infection, which can lead to fetal malformation, mental retardation and developmental delay, etc., and severe cases can cause systemic infection syndrome, called giant C...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/06A61K39/245A61P31/22G01N33/68
Inventor 邵宁生柳川王本旭杨光刘玉高亚萍王芳沈倍奋
Owner INST OF BASIC MEDICAL SCI ACAD OF MILITARY MEDICAL SCI OF PLA